SEC Comment Letter 0000000000-23-002816 to Nkarta, Inc. (NKTX)
Nkarta, Inc.
Date: March 21, 2023 · CIK: 0001787400 · Accession: 0000000000-23-002816
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-270680
Letter
United States securities and exchange commission logo March 21, 2023 Paul Hastings Chief Executive Officer Nkarta, Inc. 6000 Shoreline Court, Suite 102 South San Francisco, California 94080 Re:Nkarta, Inc. Registration Statement on Form S-3 Filed March 17, 2023 File No. 333-270680 Dear Paul Hastings: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Daniel Crawford at 202-551-7767 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Brophy Christensen, Esq.
Show Raw Text
United States securities and exchange commission logo
March 21, 2023
Paul Hastings
Chief Executive Officer
Nkarta, Inc.
6000 Shoreline Court, Suite 102
South San Francisco, California 94080
Re:Nkarta, Inc.
Registration Statement on Form S-3
Filed March 17, 2023
File No. 333-270680
Dear Paul Hastings:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Daniel Crawford at 202-551-7767 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Brophy Christensen, Esq.